• Structural Insights into TRPM3 Modulation by Neurosteroids a

  2026-06-02

  This study provides high-resolution cryo-EM structures of the TRPM3 ion channel in complex with neurosteroids, a synthetic agonist, and the anticonvulsant primidone. These insights clarify the molecular mechanisms underlying TRPM3 gating and inhibition, with implications for pain and neurodevelopmental disorder research.

• Berberine Hydrochloride: Translating Mechanism to Metabolic

  2026-06-01

  This thought-leadership article explores how Berberine Hydrochloride serves as a bridge between mechanistic metabolic disease research and translational therapeutic strategies. Integrating recent advances in AMPK activation, inflammasome modulation, and lipid metabolism, we provide actionable guidance for researchers. Strategic context is added by connecting Berberine’s bioactivity to inflammation pathways and highlighting its role in competitive experimental workflows.

• D-N-Acetylgalactosamine: Technical Use in Brain Glycoprotein

  2026-06-01

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite designed for precise analysis of glycoprotein constituents and glycosylation pathways in neurological research. It is not suitable for protocols requiring ethanol solubility or long-term storage of prepared solutions, making proper handling critical for reproducible results.

• Optimizing Immunoassays with c-Myc tag Peptide: Protocols &

  2026-05-31

  The c-Myc tag Peptide streamlines displacement of c-Myc-tagged fusion proteins, enhancing immunoassay precision and reproducibility in transcription factor and oncogene research. This article delivers evidence-based protocols, troubleshooting strategies, and cross-validated insights for maximizing assay specificity and translational relevance.

• SIRT1-Regulated Ran Lactylation Drives Astrocyte Polarizatio

  2026-05-30

  This study uncovers a mechanism by which lactate accumulation after spinal cord injury promotes astrocyte polarization. The key innovation is identifying SIRT1-regulated lactylation of Ran at lysine 123 as a control point for STAT3 nuclear transport and the A2 astrocyte phenotype, elucidating a direct metabolic-epigenetic link in CNS injury responses.

• HyperTrap Heparin HP Column: Advanced Affinity for Stemness

  2026-05-29

  The HyperTrap Heparin HP Column leverages high ligand density and superior resolution to isolate key regulators of cancer cell stemness, enabling more precise downstream analysis. Its robust chemical stability and plug-and-play compatibility make it a standout tool for researchers working with complex biomolecules or challenging purification workflows.

• PP 2 (AG 1879): Optimizing Src Kinase Inhibition in Cell Sig

  2026-05-29

  PP 2 (AG 1879) delivers potent, selective Src kinase inhibition to dissect cancer and immune cell signaling, with robust workflows for cytoskeletal and decidualization studies. Discover protocol enhancements, troubleshooting tactics, and fresh insights from recent pathway research for reproducible results.

• Pharmacokinetic Evaluation of RG108 for In Vivo DNMT Inhibit

  2026-05-28

  This study investigates the pharmacokinetics of RG108, a non-nucleosidic DNA methyltransferase inhibitor, in rats—addressing a critical gap for in vivo epigenetic modulation without cytotoxicity. The findings establish that RG108 achieves therapeutically relevant plasma and tissue concentrations, supporting its use in translational research for gene regulation beyond oncology.

• Perospirone Inhibits Kv1.5 Channels in Coronary Arterial Cel

  2026-05-28

  This study establishes that Perospirone, a second-generation antipsychotic, acts as a potent inhibitor of vascular Kv1.5 channels in coronary arterial smooth muscle cells—a previously unrecognized off-target effect. These findings broaden the understanding of Perospirone’s pharmacological profile and highlight important implications for both neuropsychiatric and cardiovascular research models.

• CHIR 99021 Trihydrochloride: Precision GSK-3 Inhibitor for S

  2026-05-27

  CHIR 99021 trihydrochloride is a potent, selective GSK-3 inhibitor used to regulate stem cell fate and glucose metabolism in vitro and in vivo. It enables controlled modulation of self-renewal and differentiation in human organoid systems and supports translational research in type 2 diabetes. This article details its mechanism, protocol parameters, and evidence benchmarks for reproducible research.

• Recent Advances in Ibuprofen Synthesis and COX Inhibitor Res

  2026-05-27

  This review details significant progress over the past decade in the synthesis of ibuprofen and naproxen, emphasizing new practical and asymmetric synthetic routes. The findings have immediate relevance for researchers seeking more efficient, selective, and scalable preparation of these key nonsteroidal anti-inflammatory drugs (NSAIDs), which are central to inflammation pathway research and COX inhibition studies.

• Trelagliptin Succinate: Enhancing Diabetes and Bone Research

  2026-05-26

  Trelagliptin succinate (SYR-472 succinate) empowers researchers with streamlined, high-fidelity protocols for type 2 diabetes and bone biology studies, thanks to its long-acting DPP-4 inhibition and robust multi-pathway activity. This guide unpacks advanced workflows, troubleshooting strategies, and new mechanistic insights for preclinical and translational research.

• PKH26 Red Fluorescent Cell Linker Kit: Practical Use & QC Gu

  2026-05-26

  The PKH26 Red Fluorescent Cell Linker Kit addresses the need for stable, membrane-specific labeling for cell tracing and proliferation detection in both in vitro and in vivo research. It should be used exclusively for labeling cell membrane lipid regions, not for intracellular or non-membrane applications.

• Gallein: G Protein βγ Subunit Inhibitor for Translational Mo

  2026-05-26

  Gallein empowers researchers to dissect GPCR signaling with precision, enabling robust workflows for cancer, immunology, and metabolic disease models. This article provides actionable guidance for protocol design, troubleshooting, and experimental optimization, bridging mechanistic insights with applied research.

• Bestatin (Ubenimex): Precision Aminopeptidase Inhibition in

  2026-05-25

  Bestatin (Ubenimex) offers unrivaled selectivity for aminopeptidase B and N, enabling detailed dissection of protease-driven pathways in multidrug resistance and plant hormone signaling. This guide demystifies experimental design, troubleshooting, and advanced applications, drawing on the latest chemical genetics and translational cancer research.

450 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page